Hologic Inc. Stock
Hologic Inc. Stock
There is an upward development for Hologic Inc. compared to yesterday, with an increase of €2.00 (2.820%).
With 16 Buy predictions and not the single Sell prediction the community is currently very high on Hologic Inc..
With a target price of 83 € there is a slightly positive potential of 16.08% for Hologic Inc. compared to the current price of 71.5 €.
So far the community has only identified positive things for Hologic Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Hologic Inc. in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Hologic Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Hologic Inc. | 2.820% | 0.704% | 0.704% | -5.995% | 11.025% | 31.386% | 70.238% |
| Boston Scientific | 0.740% | -0.730% | 7.937% | 42.647% | 32.193% | 88.001% | 105.687% |
| Waters Corp. | 2.070% | 2.648% | -5.418% | 10.556% | -1.159% | 18.452% | 53.077% |
| Illumina Inc. | -5.450% | -4.165% | -7.092% | -38.410% | -14.770% | -65.786% | -62.274% |
Comments
Hologic, Inc. (NASDAQ: HOLX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for HOLX provided by MarketBeat
Hologic, Inc. (NASDAQ: HOLX) had its price target raised by analysts at JPMorgan Chase & Co. from $85.00 to $91.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for HOLX provided by MarketBeat
Hologic, Inc. (NASDAQ: HOLX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $90.00 price target on the stock.
Show more
Ratings data for HOLX provided by MarketBeat
News
Time to buy these 3 healthcare companies that raised revenue guidance?
The new year brings a clean slate heading into the fourth-quarter earnings season. Companies can usually gauge if their previous forecasts were in line or need to be adjusted to warn or prepare
